• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脐尿管腺癌:一种采用FOLFOX化疗方案治疗的罕见原发性癌症。

Urachal Adenocarcinoma: A Rare Primary Cancer Managed With FOLFOX Chemotherapy.

作者信息

Patel Jay, Villegas Augusto

机构信息

Digestive Disease Institute, Cleveland Clinic Foundation, Cleveland, USA.

Hematology and Oncology, Florida Cancer Specialists, Fleming Island, USA.

出版信息

Cureus. 2023 Aug 21;15(8):e43849. doi: 10.7759/cureus.43849. eCollection 2023 Aug.

DOI:10.7759/cureus.43849
PMID:37736429
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10510567/
Abstract

Urachal adenocarcinoma (UA) represents a rare subset of bladder tumors involving a urachal remnant. Incidental gross hematuria is often the only presenting symptom, with patients often presenting late in their course, thereby imparting an overall poor prognosis. Although there are prior case reports, there is little literature reported and no standardized treatment guidelines. We report a case of a middle-aged male who presented with incidental gross hematuria after a fall. Workup indicated the presence of a calcified bladder dome mass and pathology reported a primary urachal adenocarcinoma with pelvic nodal involvement. Patient underwent surgical resection and subsequent adjuvant, systemic chemotherapy regimen with leucovorin, fluorouracil, and oxaliplatin (FOLFOX). We hope to bring greater awareness to this rare cause of bladder malignancy.

摘要

脐尿管腺癌(UA)是膀胱肿瘤中涉及脐尿管残余的一种罕见亚型。偶然出现的肉眼血尿往往是唯一的临床表现症状,患者常在病程晚期才就诊,因此总体预后较差。尽管之前有病例报告,但相关文献报道较少,且没有标准化的治疗指南。我们报告了一例中年男性病例,该患者在跌倒后出现偶然肉眼血尿。检查发现膀胱顶部有一个钙化肿块,病理报告为原发性脐尿管腺癌伴盆腔淋巴结转移。患者接受了手术切除,随后接受了亚叶酸钙、氟尿嘧啶和奥沙利铂(FOLFOX)的辅助全身化疗方案。我们希望提高对这种罕见的膀胱恶性肿瘤病因的认识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f899/10510567/05f2a07baf3a/cureus-0015-00000043849-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f899/10510567/766e749d87f6/cureus-0015-00000043849-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f899/10510567/33912a899544/cureus-0015-00000043849-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f899/10510567/05f2a07baf3a/cureus-0015-00000043849-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f899/10510567/766e749d87f6/cureus-0015-00000043849-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f899/10510567/33912a899544/cureus-0015-00000043849-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f899/10510567/05f2a07baf3a/cureus-0015-00000043849-i03.jpg

相似文献

1
Urachal Adenocarcinoma: A Rare Primary Cancer Managed With FOLFOX Chemotherapy.脐尿管腺癌:一种采用FOLFOX化疗方案治疗的罕见原发性癌症。
Cureus. 2023 Aug 21;15(8):e43849. doi: 10.7759/cureus.43849. eCollection 2023 Aug.
2
Small Bowel Obstruction Due to Metastatic Urachal Adenocarcinoma: A Rare Presentation.转移性脐尿管腺癌导致的小肠梗阻:一种罕见的表现。
Cureus. 2021 Nov 18;13(11):e19705. doi: 10.7759/cureus.19705. eCollection 2021 Nov.
3
Urachal carcinoma: surgical and chemotherapeutic options.脐尿管癌:手术及化疗选择
Expert Rev Anticancer Ther. 2006 Dec;6(12):1715-21. doi: 10.1586/14737140.6.12.1715.
4
Robotic assisted laparoscopic partial cystectomy and urachal resection for urachal adenocarcinoma.机器人辅助腹腔镜部分膀胱切除术和脐尿管切除术治疗脐尿管腺癌。
Int Braz J Urol. 2009 Sep-Oct;35(5):609. doi: 10.1590/s1677-55382009000500014.
5
Primary urachal adenocarcinoma: Case report.原发性脐尿管腺癌:病例报告
Int J Surg Case Rep. 2024 Jul;120:109791. doi: 10.1016/j.ijscr.2024.109791. Epub 2024 May 25.
6
Metastatic urachal cancer responding to FOLFOX chemotherapy.对FOLFOX化疗有反应的转移性脐尿管癌。
Can J Urol. 2010 Apr;17(2):5120-3.
7
[Case of urachal cancer treated by neoadjuvant chemotherapy with FOLFOX4 (oxaliplatin, 5-FU and leukovolin)].[采用FOLFOX4(奥沙利铂、5-氟尿嘧啶和亚叶酸钙)新辅助化疗治疗脐尿管癌的病例]
Hinyokika Kiyo. 2008 Aug;54(8):557-9.
8
Urachal Adenocarcinoma: a Case Report and Review of the Literature.脐尿管腺癌:一例报告及文献复习
Indian J Surg Oncol. 2023 Sep;14(3):677-681. doi: 10.1007/s13193-023-01736-6. Epub 2023 Mar 27.
9
Concurrent urachal abscess and florid cystitis glandularis masquerading as malignancy: a case report and literature review.同时并发脐尿管脓肿和滤泡性膀胱炎伪装为恶性肿瘤:病例报告及文献复习。
BMC Surg. 2022 Mar 21;22(1):105. doi: 10.1186/s12893-021-01430-w.
10
Urachal adenocarcinoma: a rare case report.脐尿管腺癌:一例罕见病例报告。
Radiol Case Rep. 2016 Dec 1;12(1):65-69. doi: 10.1016/j.radcr.2016.10.019. eCollection 2017 Mar.

引用本文的文献

1
Primary urachal adenocarcinoma treated with partial cystectomy - Case report.采用膀胱部分切除术治疗原发性脐尿管腺癌——病例报告
Int J Surg Case Rep. 2025 Jun;131:111449. doi: 10.1016/j.ijscr.2025.111449. Epub 2025 May 16.
2
Efficacy of Keratin AE1/AE3 Staining in Evaluating Resection Margins of a Urachal Remnant and Improving Surgical Precision and Outcomes: A Case Report.角蛋白AE1/AE3染色在评估脐尿管残余物切除边缘及提高手术精度和效果中的作用:一例报告
Cureus. 2024 Jun 26;16(6):e63197. doi: 10.7759/cureus.63197. eCollection 2024 Jun.

本文引用的文献

1
Current Management of Urachal Carcinoma: An Evidence-based Guide for Clinical Practice.脐尿管癌的当前管理:临床实践的循证指南
Eur Urol Open Sci. 2022 Mar 14;39:1-6. doi: 10.1016/j.euros.2022.02.009. eCollection 2022 May.
2
Small Bowel Obstruction Due to Metastatic Urachal Adenocarcinoma: A Rare Presentation.转移性脐尿管腺癌导致的小肠梗阻:一种罕见的表现。
Cureus. 2021 Nov 18;13(11):e19705. doi: 10.7759/cureus.19705. eCollection 2021 Nov.
3
Survival benefit of chemotherapy in a contemporary cohort of metastatic urachal carcinoma.
当代转移性脐尿管癌队列中化疗的生存获益
Urol Oncol. 2022 Apr;40(4):165.e9-165.e15. doi: 10.1016/j.urolonc.2021.09.008. Epub 2021 Oct 20.
4
The Prognosis and Oncological Predictor of Urachal Carcinoma of the Bladder: A Large Scale Multicenter Cohort Study Analyzed 203 Patients With Long Term Follow-Up.膀胱脐尿管癌的预后及肿瘤学预测因素:一项对203例患者进行长期随访分析的大规模多中心队列研究
Front Oncol. 2021 May 31;11:683190. doi: 10.3389/fonc.2021.683190. eCollection 2021.
5
Successful treatment of locally advanced urachal adenocarcinoma with peri-operative gemcitabine - cisplatin combination therapy: a case report and perspective on targeted therapies.围手术期吉西他滨 - 顺铂联合治疗成功治愈局部晚期脐尿管腺癌:一例病例报告及靶向治疗的观点
Cent European J Urol. 2020;73(4):476-481. doi: 10.5173/ceju.2020.0176. Epub 2020 Nov 20.
6
Management of urachal cancer: A consensus statement by the Canadian Urological Association and Genitourinary Medical Oncologists of Canada.脐尿管癌的管理:加拿大泌尿外科协会和加拿大泌尿生殖系统医学肿瘤学家的共识声明
Can Urol Assoc J. 2020 Mar;14(3):E57-E64. doi: 10.5489/cuaj.5946. Epub 2019 Jul 23.
7
Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomas.70 例脐尿管腺癌中的致病和可靶向的基因改变。
Int J Cancer. 2018 Oct 1;143(7):1764-1773. doi: 10.1002/ijc.31547. Epub 2018 May 10.
8
Urachal adenocarcinoma: a rare case report.脐尿管腺癌:一例罕见病例报告。
Radiol Case Rep. 2016 Dec 1;12(1):65-69. doi: 10.1016/j.radcr.2016.10.019. eCollection 2017 Mar.
9
Genetics and biological markers in urachal cancer.脐尿管癌中的遗传学与生物标志物
Transl Androl Urol. 2016 Oct;5(5):655-661. doi: 10.21037/tau.2016.04.01.
10
Malignant urachal neoplasms: A population-based study and systematic review of literature.恶性脐尿管肿瘤:一项基于人群的研究及文献系统综述
Urol Oncol. 2017 Jan;35(1):33.e11-33.e19. doi: 10.1016/j.urolonc.2016.07.021. Epub 2016 Sep 1.